Related Experiment Videos
Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration
Kosaku Shiragami1, Zenzo Fujii, Toshihiro Sakumura
1Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Insights
Contrast agents can worsen long-term kidney function, but prophylactic hemodiafiltration (HDF) effectively mitigates this risk, improving outcomes for patients with chronic renal insufficiency.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Limited research exists on contrast agent effects on long-term renal function.
- Uncertainty surrounds the effectiveness of prophylactic hemodiafiltration (HDF) for contrast-induced nephropathy.
Purpose of the Study:
- To investigate the long-term impact of contrast agents on renal function.
- To evaluate the efficacy of prophylactic hemodiafiltration (HDF) in preventing contrast-induced nephropathy.
Main Methods:
- Patients with heart disease were categorized based on serum creatinine levels (Scr).
- Groups included normal Scr (N), elevated Scr without HDF (D1), and elevated Scr with HDF (D2).
- Linear regression of 1/Scr was used to analyze renal function changes before and after contrast agent use, comparing slopes (constant k).
Main Results:
- Group D1 (without HDF) demonstrated a significant decrease in the renal function slope (k) post-contrast agent administration (p<0.05).
- Hemodiafiltration (HDF) was administered for 2 hours to aid contrast agent removal.
Conclusions:
- Contrast agent administration is an independent risk factor for chronic renal insufficiency.
- Prophylactic hemodiafiltration (HDF) significantly improves long-term renal function outcomes in patients exposed to contrast agents.
Background:
There have been few studies regarding the effect of contrast agent on long-term renal function and, moreover, there are still many uncertainties regarding the efficacy of prophylactic hemodiafiltration (HDF) for contrast-induced nephropathy.
Methods And Results:
Patients with heart disease and a serum creatinine level (Scr) of less than 1.2 mg/dl were classified as Group N (20 patients), those with Scr of at least 1.2 mg/dl but less than 2.0 mg/dl were classified as Group D1 (10 patients without HDF) and D2 (15 patients with HDF), respectively. For each group, a linear regression of 1/Scr was extrapolated using Scr measured more than 3 times during each period that was longer than 3 months before and after use of a contrast agent, and the slopes (constant k) thereof were compared. To remove the contrast agent, HDF was performed for 2 h. Group D1 showed a significant decrease in the k after use of the contrast agent (p<0.05).
Conclusion:
Use of a contrast agent is an independent factor that promotes chronic renal insufficiency and prophylactic HDF was found to effectively improve the long-term outcome of decreased renal function.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...